Compounded tirzepatide
Sold by Coivas · every compounded tirzepatide record
The register has not established whether this program ships a vial, a pen, or another form. That is a gap in our record, not a statement about the company.
What you actually pay
Per month
$229
| Medication · Comparison table, standard monthly | $229 |
|---|
Added from the figures recorded below.
Price
| Term | Per month | Charged today |
|---|---|---|
| Comparison table, standard monthly “Tirzepatide (monthly) $229 After intro period” | Per month$229 | Charged today$229 |
We earn nothing from this link. Coivas has no commercial arrangement with Treatment Registry, and its record here is kept to the same standard as every other.
History
One reading so far. A price history appears here after the next verification pass.
- September 2, 2026 — Entry added to the register
Sourcing and terms
| States | All 50 states |
|---|---|
| Prescriber | Both |
| Cancellation | “Can I cancel at any time? Yes — there are no long-term contracts or cancellation fees. You can pause or cancel your plan at any time from your member portal.” |
Not yet checked: pharmacy, membership and consult fee.
Recorded from coivas.com. Unlike the price rows above, these carry a summary rather than a word-for-word quotation, so they are not shown in quotation marks.
Notes
- 1. September 2, 2026 — All-inclusive pricing (consultation, medication, shipping, support bundled). Home page defaults to showing semaglutide's intro pricing prominently; the exact tirzepatide intro-period figure wasn't printed outside the comparison table (only its standard $229/mo post-intro price is stated in visible text).
Treatment Registry is an independent editorial record. It is not a government registry, a licensing body, or a certification. An entry means we recorded what a company published on a given date. It does not mean we recommend the program, and it does not mean the program is approved by anyone.